MedTrace Logo

International Active Surveillance Study of Women Taking Oral Contraceptives (INAS-OC)

NCT00335257 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 85109

Last updated 2019-08-07

Study results available
· View outcomes & findings →

Summary

The study compares the short- and long-term risks of a 24-day regimen of a drospirenone-containing oral contraceptive with the risks of established oral contraceptives in a study population that is representative for the actual users of the individual preparations.

Conditions

  • Contraception

Sponsors & Collaborators

  • Bayer

    collaborator INDUSTRY

  • Center for Epidemiology and Health Research, Germany

    lead OTHER

Principal Investigators

  • Juergen C Dinger, MD, PhD · Center for Epidemiology and Health Research, Berlin, Germany

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-08-31
Primary Completion
2013-01-31
Completion
2013-03-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00335257 on ClinicalTrials.gov